OS Therapies Incorporated (OSTX)
NYSE: OSTX · Pharmaceutical Preparations · Rockville, MD · filing with the SEC since 2019
Who owns OS Therapies Incorporated
As filed with the SECHolders of 5% or more
3
Ayala Pharmaceuticals, Inc. holds 9.99% of Common Stock, par value $0.001 per share, as its SCHEDULE 13G filed Apr 16, 2025 says.
Directors and officers
11
report now, of 13 people on the record since 2024. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
Ayala Pharmaceuticals, Inc.
SCHEDULE 13G · filed Apr 16, 2025 · Common Stock, par value $0.001 per share
Thomas A. Satterfield, Jr.
SCHEDULE 13G/A · filed Aug 13, 2025 · Common Stock, par value $0.001 per share · 5.9% in Feb 12, 2025
Shalom Auerbach
SCHEDULE 13D/A · filed Aug 18, 2025 · Common Stock, par value $0.001 per share · 9.9% in May 9, 2025
What OSTX reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Patent License Acquisition
A company bought · asset acquisition · owns, named in the 10-K filed Mar 31, 2026
2 subsidiaries in 2 countries, from the list filed with the 10-K filed Mar 31, 2026.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Nov 12, 2025 to Nov 12, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
No open-market trade is on the record for these years.
Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.